CSI Market
Sign In | Register

Apexigen Inc (APGN) Annual Cash Flow Statement

Annual · GAAP · USD millions
Access APGN quarterly Cash Flow →
Cash flow data covering Apexigen Inc– offers a view into how Dec 31 2022's cash position has developed alongside business activity.
View historic periods: Download as CSV:
Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.
Annual Report, GAAP in USD millions
ITEM 		(Dec 31 2022)
12 Months 		(Dec 31 2021)
Operating Activities
Income-32.07
Depreciation & amortization0.11
Amortization of Other Assets0.00
Extraordinary Item, Gain (Loss), Insurance Assets, Accretion Expense0.00
Restructuring & Impairment Charges0.00
Provision For Loan Losses Expensed0.00
Inventories Decrease /-Increase0.00
R & D, Environmental and Other Expense0.00
Gain (Loss) on Disposition of Property Plant Equipment0.00
Share-based Compensation1.88
Income (Loss) from Equity Method Investments0.00
Increase (Decrease) in Derivative Liabilities-0.08
General And Administrative Expenses Paid By Related Party Under Promissory Note-
Gain Loss On Derivative Instruments Net Pretax-
Expense From Exercise Of Restricted Stock Awards-
Investment Income Net Amortization Of Discount And Premium-0.03
Amortization Of Deferred Charges0.74
Increase Decrease Fair Value Of Liability For Common Stock To Be Issued-0.21
Noncashlease Expense0.40
Increase Decrease In Contract With Customer Liability2.05
Increase Decrease In Operating Lease Liability-0.42
Income taxes0.00
Gain (Loss) on Sale of Investments0.00
Accounts Receivable0.00
Increase (Decrease) in Accounts Payable0.32
Increase (Decrease) in Accrued Liabilities-3.13
Deferred Revenue and Customer Advances and Deposits0.00
Increase (Decrease) in Prepaid Expense and Other Assets-0.76
Other Working Capital-0.07
Other Noncash Income (Expense)0.00
Other net0.00
Payments for (Proceeds from) Other Operating Activities0.57
Discontinued operations0.00
Net Cash flow from Operating Activities-30.69
Investing Activities
Capital Expenditures-0.06
Sale of Capital Items0.00
Proceeds from Sale and Maturity of Marketable Securities29.96
Payments to Acquire Marketable Securities-18.95
Real Estate Investments0.00
Restricted Cash and Investments Increase (Decrease)0.00
Payments for (Proceeds from) Loans0.00
Payments for (Proceeds from) Deposits0.00
Payments for (Proceeds from) Other Investments0.00
Payments for (Proceeds from) Federal Reserve and FHLB0.00
Acquisition Net of Cash Acquired0.00
Interest in Subsidiaries and Affiliates0.00
Sale of businesses0.00
Accounts payable0.00
Receivables0.00
Payments for (Proceeds from) Other Investing Activities0.00
Other Net0.00
Discontinued operations0.00
Net Cash Flow from Investing Activities10.96
Financing Activities
Short-term debt Net0.00
Other borrowing transactions-0.39
Long-term debt - borrowings0.00
Long-term debt - repayments0.00
Federal Home Loan Bank and Federal Funds0.00
Issuances / -repurchases of Comm. Stock2.61
Partnership and Parent Transactions0.00
Issuances / -repurchases of Pref. Stock0.00
Deposits, Annuities, Contract Holders Funds0.00
Other financing activities net0.00
Other net-9.22
Proceeds From Non Convertible Debt-
Proceeds From Business Combination And Private Offering18.09
Payments Of Transaction Costs-
Payments of Dividends, Preferred Stock and Preference Stock0.00
Dividends paid0.00
Net Cash Flow from Financing Activities11.10
Effect of exchange rate on cash flow0.00
Discontinued operations0.00
Free Cash Flow-30.75
Total Cash Flow-8.64
4 historic quarters locked

Sign in to unlock the full Apexigen Inc cash flow history.

Sign In Create Free Account

About Apexigen Inc Annual Cash Flow Statement

What this statement shows

This page presents issuer-reported cash flow data, including operating, investing, financing, net, and free cash flow, as disclosed in SEC filings and normalized by CSIMarket.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - normalization in the CSIMarket.com database.
  • Accession: 0000950170-23-041401

Figures are derived from filed reports and may be restated. Historical data is subject to revision.

Untitled Document 





                    


    



  Get the full CSIMarket dataset:
  Subscribe
  API
  License